Metabolic syndrome among infertile women with polycystic ovary syndrome

Padubidri, 2011, Disorders of the ovary and benign tumours, 369 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril, 81, 19, 10.1016/j.fertnstert.2003.10.004 Asmathulla, 2013, Insulin resistance and its relation to inflammatory status and serum lipids among young women with PCOS, Int J Reprod Contracept Obstet Gynecol, 2, 325, 10.5455/2320-1770.ijrcog20130913 Third Report of the National Cholesterol Education Program (NCEP), 2002, Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation, 106, 3143, 10.1161/circ.106.25.3143 Dokras, 2005, Screening women with polycystic ovary syndrome for metabolic syndrome, Obstet Gynecol, 106, 131, 10.1097/01.AOG.0000167408.30893.6b Wild, 2000, Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study, Clin Endocrinol (Oxf), 52, 595, 10.1046/j.1365-2265.2000.01000.x Haffner, 2003, Low insulin sensitivity [(Si)=0)] in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?, Diabetes Care, 26, 2796, 10.2337/diacare.26.10.2796 Lepor, 2001, National Cholesterol Education Program Adult Treatment Panel III. Summary of the third report of the National Cholesterol Education Program Adult Treatment Panel III, Rev Cardiovas Med, 2, 160 Legro, 2004, Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls, Obstet Gynecol Surv, 59, 141, 10.1097/01.OGX.0000109523.25076.E2 Mandrelle, 2012, Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India, J Hum Reprod Sci, 5, 26, 10.4103/0974-1208.97791 Grundy, 2005, American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 Shroff, 2007, Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria, Fertil Steril, 88, 1389, 10.1016/j.fertnstert.2007.01.032 Vrbíková, 2005, Metabolic syndrome in young Czech women with polycystic ovary syndrome, Hum Reprod, 20, 3328, 10.1093/humrep/dei221 Cheung, 2008, Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome, Hum Reprod, 23, 1431, 10.1093/humrep/den090 Essah, 2006, Metabolic syndrome in women with polycystic ovary syndrome, Fertil Steril, 86, S18, 10.1016/j.fertnstert.2006.04.013 Hahn, 2007, Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome, Exp Clin Endocrinol Diabetes, 115, 130, 10.1055/s-2007-967093 Soares, 2008, Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome, Fertil Steril, 89, 649, 10.1016/j.fertnstert.2007.03.081 Goverde, 2009, Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria, Hum Reprod, 24, 710, 10.1093/humrep/den433 Janssen, 2004, Waist circumference and not body mass index explains obesity related health risks, Am J Clin Nutr, 79, 379, 10.1093/ajcn/79.3.379